Gwo Xi Stem Cell Applied Technology Co., Ltd.

As of June 30, 2026, Gwo Xi Stem Cell Applied Technology Co., Ltd. carries a market capitalization of 2.05B, placing it among publicly traded companies globally. Its enterprise value stands at 2.04B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Gwo Xi Stem Cell Applied Technology Co., Ltd. has 95.95M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Gwo Xi Stem Cell Applied Technology Co., Ltd. maintains a current ratio of 3.80, meaning it holds 3.8x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, Gwo Xi Stem Cell Applied Technology Co., Ltd.'s stock has declined approximately 23.09% over the past 52 weeks. The 50-day moving average sits at 21.24, while the 200-day moving average is 22.07.

As of June 30, 2026, Gwo Xi Stem Cell Applied Technology Co., Ltd. holds 361.74M in cash and equivalents against 356.03M in total debt, resulting in a net debt position of -44.72M. Total book value stands at 746.93M, with working capital of 285.60M providing operational flexibility.